Research on Exosomes/Extracellular Vesicles Is Growing and Focusing on Their Potential as Circulating Biomarkers for Liquid Biopsy Development
from Genetic Engineering News by Gary Oosta, Ph.D. & Enal Razvi, Ph.D.
Select Biosciences has been tracking the exosomes landscape for the past several years, and in this GEN Report we present a snapshot of the exosomes market landscape excerpted from Select Biosciences’ recent market report. Here we present the evolution of this field over the past several years as well as both qualitative as well as quantitative market parameters.
Growth of the Exosomes Field and Its Segmentation
Researchers are pursuing scientific questions in the exosomes and extracellular vesicles (EVs) field worldwide, making this field a granular and bottom-up effort of researchers. For this reason, we harvested 20,199 academic publications that constitute the entire exosomes/EVs publication body. We believe an analysis of publications en bloc is the best approach to analysis of this geographically dispersed field that is based on research arising from many different fields, such as cancer research, neuroscience, stem cell research, reproductive medicine, etc. Figure 1 presents the growth of publications in the exosomes/EVs field as a means to frame the size of the field.
The compound annual growth rate (CAGR) for the past five-year period for this space is 17%.
Select Biosciences further sought to segment the exosomes/EVs space into its components, but stratifying out the publications database by area of focus, as presented in Figure 2.
As is clear from Figure 2, the exosomes/EVs field is diverse and composed of several elements—from tools to disease classes, from sample types to genetic elements. Taken together, these constitute the current ensemble of the exosomes/EVs field. Cancer, as would be expected, occupies a decent share of 8% of the total publications pool.